International Journal of Nephrology最新文献

{"title":"Renal Transplant Pathology: Demographic Features and Histopathological Analysis of the Causes of Graft Dysfunction.","authors":"Shaarif Bashir,&nbsp;Mudassar Hussain,&nbsp;Azhar Ali Khan,&nbsp;Usman Hassan,&nbsp;Khawaja Sajid Mushtaq,&nbsp;Maryam Hameed,&nbsp;Usman Ayub Awan","doi":"10.1155/2020/7289701","DOIUrl":"https://doi.org/10.1155/2020/7289701","url":null,"abstract":"<p><strong>Background: </strong>Renal transplant has emerged as a preferred treatment modality in cases of end-stage renal disease; however, a small percentage of cases suffer from graft dysfunction.</p><p><strong>Aim: </strong>To evaluate the renal transplant biopsies and analyze the various causes of graft dysfunction.</p><p><strong>Materials and methods: </strong>163 renal transplant biopsies, reported between 2014 and 2019 and who fulfilled the inclusion criteria, were evaluated with respect to demographics, clinical, histological, and immunohistochemical features.</p><p><strong>Results: </strong>Of 163 patients, 26 (16%) were females and 137 (84%) were males with a mean age of 34 ± 7 years. 53 (32.5%) cases were of rejection (ABMR and TCMR), 1 (0.6%) was borderline, 15 were of IFTA, and rest of 94 cases (57.7%) belonged to the others category. SCr (serum creatinine) in cases of rejection was 3.85 ± 0.55 mg/dl. Causes of early graft dysfunction included active ABMR (7.1 ± 4.7 months), acute TCMR (5.5 months), and acute tubular necrosis (after 6 ± 2.2 months of transplant) while the causes of late rejection were CNIT and IFTA (34 ± 4.7 and 35 ± 7.8 months, respectively).</p><p><strong>Conclusion: </strong>Renal graft dysfunction still remains a concerning area for both clinicians and patients. Biopsy remains the gold standard for diagnosing the exact cause of graft dysfunction and in planning further management.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2020 ","pages":"7289701"},"PeriodicalIF":2.1,"publicationDate":"2020-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/7289701","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38854680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bidirectional Interaction of Thyroid-Kidney Organs in Disease States.","authors":"Fateme Shamekhi Amiri","doi":"10.1155/2020/5248365","DOIUrl":"https://doi.org/10.1155/2020/5248365","url":null,"abstract":"<p><strong>Purpose: </strong>Thyroid hormones play an important role in growth, development, and physiology of the kidney. The kidney plays a key role in the metabolism, degradation, and excretion of thyroid hormones and its metabolites. The aim of this study is to investigate the prevalence of disease states of thyroid-kidney organs and detecting the correlation between thyroid and kidney function abnormalities.</p><p><strong>Materials and methods: </strong>In this retrospective study, a total of forty-five patients with thyroid and kidney dysfunction were investigated. Clinical features, laboratory data at initial presentation, management, and outcomes were collected. The paper has been written based on searching PubMed and Google Scholar to identify potentially relevant articles or abstracts. Median, percentage, mean ± standard deviation (SD), and the two-tailed <i>t</i>-test were used for statistical analyses. The correlation between variables was assessed by Pearson's, Spearman's correlation tests and regression analyses.</p><p><strong>Results: </strong>The mean ± SD of age of study patients was 48.2 ± 22.93 years (ranging from 1 to 90 years). There was no correlation between serum thyroid-stimulating hormone, free thyroxine levels with estimated glomerular filtration rate, and proteinuria. No association between antimicrosomal antibodies with estimated glomerular filtration rate was seen. Cardiovascular disease was the most common complication of overt hypothyroidism in kidney dysfunction patients.</p><p><strong>Conclusion: </strong>The present study showed more prevalence of primary hypothyroidism in comparison with other thyroid dysfunctions in patients with kidney dysfunction. Reduced mean values of thyroid function profiles after treatment suggest that this thyroid disease should be considered and ameliorated with thyroid hormone replacement therapy in patients with kidney disease.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2020 ","pages":"5248365"},"PeriodicalIF":2.1,"publicationDate":"2020-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/5248365","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38735036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Comparison of Urine Dilution Ability between Adult Dominant Polycystic Kidney Disease, Other Chronic Kidney Diseases, and Healthy Control Subjects: A Case-Control Study.","authors":"M H Malmberg,&nbsp;F H Mose,&nbsp;E B Pedersen,&nbsp;J N Bech","doi":"10.1155/2020/4108418","DOIUrl":"https://doi.org/10.1155/2020/4108418","url":null,"abstract":"<p><p>The final dilution of urine is regulated via aquaporin-2 water channels in the distal part of the nephron. It is unclear whether urine dilution ability in autosomal dominant polycystic kidney disease patients (ADPKD patients) differs from other patients with similar degree of impaired renal function (non-ADPKD patients). The purpose of this case control study was to measure urine dilution ability in ADPKD patients compared to non-ADPKD patients and healthy controls. <i>Methods</i>. Eighteen ADPKD, 16 non-ADPKD patients (both with chronic kidney disease, stage I-IV), and 18 healthy controls received an oral water load of 20 ml/kg body weight. Urine was collected in 7 consecutive periods. We measured free water clearance (C_H2O), urine osmolality, urine output, fractional excretion of sodium, urine aquaporin2 (u-AQP2), and urine epithelial sodium channel (u-ENaC). Blood samples were drawn four times (at baseline, 2 h, 4 h, and 6 hours after the water load) for analyses of plasma osmolality, vasopressin, renin, angiotensin II, and aldosterone. Brachial and central blood pressure was measured regularly during the test. <i>Results</i>. The three groups were age and gender matched, and the patient groups had similar renal function. One hour after water load, the ADPKD patients had an increased C_H2O compared to non-ADPKD patients (2.97 ± 2.42 ml/min in ADPKD patients vs. 1.31 ± 1.50 ml/min in non-ADPKD patients, <i>p</i>0.029). The reduction in u-AQP2 and u-ENaC occurred earlier in ADPKD than in non-ADPKD patients. Plasma concentrations of vasopressin, renin, angiotensin II, and aldosterone and blood pressure measurements did not show any differences that could explain the deviation in urine dilution capacity between the patient groups. <i>Conclusions</i>. ADPKD patients had a higher C_H2O than non-ADPKD patients after an oral water load, and u-AQP2 and u-ENaC were more rapidly reduced than in non-ADPKD patients. Thus, urine-diluting capacity may be better preserved in ADPKD patients than in non-ADPKD patients.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2020 ","pages":"4108418"},"PeriodicalIF":2.1,"publicationDate":"2020-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/4108418","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38735035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Acute Kidney Injury Caused by Obstructive Nephropathy.","authors":"Jonathan S Chávez-Iñiguez,&nbsp;Goretty J Navarro-Gallardo,&nbsp;Ramón Medina-González,&nbsp;Luz Alcantar-Vallin,&nbsp;Guillermo García-García","doi":"10.1155/2020/8846622","DOIUrl":"https://doi.org/10.1155/2020/8846622","url":null,"abstract":"<p><p>Acute kidney injury secondary to obstructive nephropathy is a frequent event that accounts for 5 to 10% of all acute kidney injury cases and has a great impact on the morbidity and mortality in those affected. The obstruction in the urinary tract has a profound impact on kidney function due to damage produced by ischemic and inflammatory factors that have been associated with intense fibrosis. This pathology is characterized by its effects on the management of fluids, electrolytes, and the acid-base mechanisms by the renal tubule; consequently, metabolic acidosis, hyperkalemia, uremia, and anuria are seen during acute kidney injury due to obstructive nephropathy, and after drainage, polyuria may occur. Acute urine retention is the typical presentation. The diagnosis consists of a complete medical history and should include changes in urinary voiding and urgency and enuresis, history of urinary tract infections, hematuria, renal lithiasis, prior urinary interventions, and constipation. Imaging studies included tomography or ultrasound in which hydronephrosis can be seen. Management includes, in addition to drainage of the obstructed urinary tract system, providing supportive treatment, correcting all the metabolic abnormalities, and initiating renal replacement therapy when required. Although its recovery is in most cases favorable, it seems to be an undervalued event in nephrology and urology. This is because it is mistakenly believed that the resolution and recovery of kidney function is complete once the urinary tract is unobstructed. It can have serious kidney sequelae. In this review, we report the epidemiology, incidence, pathophysiological mechanisms, diagnosis, and treatment of acute kidney injury due to obstructive nephropathy.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2020 ","pages":"8846622"},"PeriodicalIF":2.1,"publicationDate":"2020-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/8846622","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38708521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hyponatraemia as a Predictor of Mortality in Medical Admissions in Ghana: A Comparative Study.","authors":"Elliot Koranteng Tannor,&nbsp;Martin Agyei,&nbsp;Abena Y Tannor,&nbsp;Afua Ofori,&nbsp;Emmanuel Akumiah,&nbsp;Yasmin Adoma Boateng","doi":"10.1155/2020/3145843","DOIUrl":"https://doi.org/10.1155/2020/3145843","url":null,"abstract":"<p><strong>Background: </strong>Hyponatraemia is the most common electrolyte abnormality in hospital admissions. It occurs in a quarter of medical admissions in Ghana, and it is associated with high mortality. Mortality has been suggested to be due to the underlying medical condition and not necessarily the hyponatraemia. We set out to compare the outcomes of patients with documented hyponatraemia as compared to those with normonatraemia in terms of mortality and length of hospital stay.</p><p><strong>Methods: </strong>We conducted a comparative analysis of patients with hyponatraemia and those with normonatraemia on the medical ward at the Komfo Anokye Teaching Hospital between May 2018 and December 2018. The medical diagnoses, demographics, and laboratory data of the patients were recorded. Participants' age and gender were matched. Student's <i>t</i>-test was used to test for differences in continuous variables when parametric and Wilcoxon signed-rank test for nonparametric variables. Multiple logistic regression was used to identify predictors of in-hospital mortality. A <i>p</i> value of <0.05 was considered statistically significant.</p><p><strong>Results: </strong>Within the study period, 846 patients with documented serum sodium were included in the study. The study involved 406 patients with hyponatraemia and 440 patients with normonatraemia. Serum albumin and protein were significantly lower in the hyponatraemia patients as compared to those with normonatraemia. The mortality rate in patients with hyponatraemia was significantly higher than those with normonatraemia (129 (31.8%) vs. 9 (22.3%); OR 1.62 (95% CI: 1.19-2.22), <i>p</i> = 0.002). In-hospital stay was longer in patients with hyponatraemia than normonatraemia (7 (4-10) vs. 6 (3-10) days) but not statistically significant (<i>p</i> = 0.09). Multiple logistic regression showed that low serum sodium (<i>p</i> < 0.001) and low serum albumin (<i>p</i> = 0.009) were the predictors of in-hospital mortality.</p><p><strong>Conclusion: </strong>Hyponatraemia is associated with significantly higher mortality than normonatraemia and predicts worse prognosis in patients on medical admission. Low serum albumin is also a predictor of mortality in medical admission.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2020 ","pages":"3145843"},"PeriodicalIF":2.1,"publicationDate":"2020-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/3145843","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38355935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Corrigendum to \"Prevalence of APOL1 Risk Variants in Afro-Descendant Patients with Chronic Kidney Disease in a Latin American Country\".","authors":"Carlos E Duran,&nbsp;Alejandro Ramírez,&nbsp;Juan G Posada,&nbsp;Johanna Schweineberg,&nbsp;Liliana Mesa,&nbsp;Harry Pachajoa,&nbsp;Mayra Estacio,&nbsp;Eliana Manzi,&nbsp;Vanessa Aros,&nbsp;Lorena Díaz,&nbsp;Victor H Garcia","doi":"10.1155/2020/8706297","DOIUrl":"https://doi.org/10.1155/2020/8706297","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1155/2019/7076326.].</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2020 ","pages":"8706297"},"PeriodicalIF":2.1,"publicationDate":"2020-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/8706297","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38689342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Association between the Activin A Serum Level and Carotid Intima-Media Thickness in Chronic Kidney Disease Patients.","authors":"Ade Yonata,&nbsp;Zulkhair Ali,&nbsp;Taufik Indrajaya,&nbsp;Erial Bahar,&nbsp;Ian Effendi,&nbsp;Novadian Suhaimi,&nbsp;Suprapti Suprapti","doi":"10.1155/2020/8893653","DOIUrl":"https://doi.org/10.1155/2020/8893653","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic kidney disease (CKD) is associated with high mortality rates, mainly as a result of cardiovascular complications. Meanwhile, recent studies have suggested a role of a homodimer protein called activin A in chronic kidney disease-mineral and bone disorder (CKD-MBD) conditions that may exist in the vascular calcification and osteolytic process. Ultrasound examination of the carotid intima-media thickness (cIMT) is a noninvasive method to assess vascular calcification. This study aimed to analyze the relationship between the activin A serum level and cIMT in patients with CKD at Mohammad Hoesin Hospital, Palembang, Indonesia.</p><p><strong>Methods: </strong>We conducted a hospital-based, cross-sectional study of consecutive CKD patients at the Department of Internal Medicine, Mohammad Hoesin Hospital, from July to November 2019. The level of activin A was measured by enzyme-linked immunosorbent assay. Meanwhile, cIMT measurements were collected by <i>B</i>-mode ultrasound imaging.</p><p><strong>Results: </strong>A total of 55 patients with CKD were included in this investigation. The median serum activin A level in these patients was 236.17 (116.33-283) pg/mL, while the median cIMT was 0.8 (0.6-1.45) mm. A relationship between the serum activin A level and cIMT (<i>r</i>  =  0.449; <i>p</i> = 0.001) was observed. During multivariate analysis with linear regression, triglyceride (<i>p</i> = 0.049), phosphate (<i>p</i> = 0.005), and activin A (<i>p</i> = 0.020) serum levels were factors associated with cIMT.</p><p><strong>Conclusion: </strong>In this study, a relationship between the activin A serum level and cIMT in patients with CKD was identified. Vascular calcification should be screened for in all CKD patients by the measurement of cIMT.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2020 ","pages":"8893653"},"PeriodicalIF":2.1,"publicationDate":"2020-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/8893653","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38689343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence, Clinical Presentation, and Outcome of Tuberculosis in Patients with Chronic Kidney Disease at a Tertiary Care Hospital in Nepal.","authors":"Ravi R Pradhan,&nbsp;Mahesh Raj Sigdel","doi":"10.1155/2020/7401541","DOIUrl":"https://doi.org/10.1155/2020/7401541","url":null,"abstract":"<p><strong>Background: </strong>Tuberculosis (TB) is a serious public health threat in low- and middle-income countries like Nepal. Chronic kidney disease (CKD) patients are at higher risk of developing new infection as well as reactivation of TB. We aimed to determine the prevalence, clinical presentations, and outcome of TB in patients with CKD in Nepal.</p><p><strong>Methods: </strong>A hospital-based cross-sectional study was performed at Tribhuvan University Teaching Hospital (TUTH), a tertiary level referral centre in Kathmandu, Nepal. We included patients older than 16 years with the diagnosis of CKD stage 3, 4, 5, and 5D (CKD 5 on maintenance dialysis); renal transplant recipients and patients living with HIV/AIDS were excluded. Tuberculosis was diagnosed based on clinical, radiological, and laboratory findings. Prior written informed consent was obtained. Approval was obtained from the Institutional Review Board of the Institute of Medicine. Data entry and statistical analysis were performed using SPSS v21.</p><p><strong>Results: </strong>A total of 401 patients with CKD were included in the study (mean age, 50.92 ± 17.98 years; 64.8% male). The prevalence of TB in CKD patients was found to be 13.7% (55), out of which 49 were newly diagnosed cases. The most common clinical presentations of TB in CKD were anorexia (85.7%), fever (83.7%), weight loss (51%), and cough (49%). Thirty-eight patients (69.1%) had extrapulmonary TB (EPTB), 12 (21.8%) had pulmonary TB, 3 (5.5%) had disseminated TB, and 2 (3.6%) had miliary TB. Only 4.1% of cases were sputum smear positive. Pleural effusion (34.2%) was the most common EPTB. At 2 months of starting antitubercular therapy, 29 patients out of the 49 newly diagnosed cases of TB (59.2%) had responded to therapy. Mortality at 2 months was 28.6% (14 died amongst 49 patients). Four out of 49 patients (8.2%) did not improve, and 2 (4%) patients were lost to follow-up.</p><p><strong>Conclusion: </strong>Prevalence and mortality of TB were higher in patients with CKD. Special attention must be given to these people for timely diagnosis and treatment as the presentation is different and diagnosis can be missed.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2020 ","pages":"7401541"},"PeriodicalIF":2.1,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/7401541","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38623561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of a Supervised Peridialytic Exercise Program on Serum Asymmetric Dimethylarginine in Maintenance Hemodialysis Patients.","authors":"Yaser A Ammar, Ahmad Awad","doi":"10.1155/2020/8878306","DOIUrl":"10.1155/2020/8878306","url":null,"abstract":"<p><p>End-stage renal disease (ESRD) patients treated with maintenance haemodialysis (MHD) have alarmingly high atherosclerotic cardiovascular disease morbidity and mortality. Nitric oxide (NO) is the principal endogenous antiatherosclerotic molecule. Increased asymmetric dimethylarginine (ADMA), an endogenous NO synthase inhibitor, was strongly implicated in endothelial dysfunction, premature atherosclerosis, vascular events, and mortality. Regular physical exercise effectively decreased serum ADMA in several patient cohorts, but this potential benefit has not been specifically explored among MHD patients. Forty-four middle-aged ESRD patients treated with thrice-weekly MHD for ≥6 months completed a 6-months regimen of peridialytic lower limb exercise comprising predialytic 10-12 stretching cycles and 20-30 minutes of intradialytic pedaling cycles. Before and after the study, predialytic haemoglobin, serum ADMA, urea, creatinine, calcium, phosphorus, and C-reactive protein (CRP) were measured. Dialysis adequacy was assessed by single-pool Kt/V. The average total physical activity (PA) level was assessed by the International Physical Activity Questionnaire (IPAQ). <i>P</i> values <0.05 denoted a statistical significance. The overall level of PA, on both categorical and continuous scales, has significantly increased after application of the exercise program. However, S. ADMA increased from a median of 2375 to 3000 ng/mL (<i>P</i>=0.016). Thirty-one patients sustained an increase in S. ADMA (ADMA_Inc), whereas 13 patients had a declining or stable S. ADMA (ADMA_Dec). Compared with ADMA_Inc, ADMA_Dec patients had significantly higher Kt/V (<i>P</i>=0.02), higher grade of the basal general PA level (<i>P</i>=0.017), and significantly fewer intradialytic hypotension episodes (IDHs) (<i>P</i>=0.019). The increase in the S. ADMA and the poststudy S. ADMA level had statistically significant positive correlations with the number of IDHs (<i>r</i> = 0.401, <i>P</i>=0.007 and <i>r</i> = 0.305, <i>P</i>=0.044, respectively). A 6-month program of combined aerobic and resistance peridialytic exercise failed to reduce S. ADMA in most MHD patients studied. A modest S. ADMA decline, however, occurred in patients with higher basal PA levels, higher Kt/V, and less IDHs. A potential exercise benefit may be promoted by a multidisciplinary approach targeting increased PA, improved dialysis efficiency, and prevention of IDHs.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2020 ","pages":"8878306"},"PeriodicalIF":1.7,"publicationDate":"2020-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604598/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38683850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparing the Efficacy and Safety of Induction Therapies for the Treatment of Patients with Proliferative Lupus Nephritis in South Africa.","authors":"Phelisa Sogayise,&nbsp;Udeme Ekrikpo,&nbsp;Ayanda Gcelu,&nbsp;Bianca Davidson,&nbsp;Nicola Wearne,&nbsp;Ugochi Okpechi-Samuel,&nbsp;Theophilus Ifeanyichukwu Umeizudike,&nbsp;Innocent Ijezie Chukwuonye,&nbsp;Ikechi Okpechi","doi":"10.1155/2020/2412396","DOIUrl":"https://doi.org/10.1155/2020/2412396","url":null,"abstract":"<p><strong>Background: </strong>Lupus nephritis (LN) can be complicated with requirement for kidney replacement therapy and death. Efficacy of induction therapies using mycophenolate mofetil (MMF) or intravenous cyclophosphamide (IVCYC) has been reported from studies, but there is limited data in Africans comparing both treatments in patients with proliferative LN.</p><p><strong>Methods: </strong>This was a retrospective study of patients with biopsy-proven proliferative LN diagnosed and treated with either MMF or IVCYC in a single centre in Cape Town, South Africa, over a 5-year period. The primary outcome was attaining complete remission after completion of induction therapy.</p><p><strong>Results: </strong>Of the 84 patients included, mean age was 29.6 ± 10.4 years and there was a female preponderance (88.1%). At baseline, there were significant differences in estimated glomerular filtration rate (eGFR) and presence of glomerular crescents between both groups (<i>p</i> ≤ 0.05). After completion of induction therapy, there was no significant difference in remission status (76.0% versus 87.5%; <i>p</i>=0.33) or relapse status (8.1% versus 10.3%; <i>p</i>=0.22) for the IVCYC and MMF groups, respectively. Mortality rate for the IVCYC group was 5.5 per 10,000 person-days of follow-up compared to 1.5 per 10,000 person-days of follow-up for the MMF group (<i>p</i>=0.11), and there was no significant difference in infection-related adverse events between both groups. Estimated GFR at baseline was the only predictor of death (OR: 1.0 [0.9-1.0]; <i>p</i>=0.001).</p><p><strong>Conclusion: </strong>This study shows similar outcomes following induction treatment with MMF or IVCYC in patients with biopsy-proven proliferative LN in South Africa. However, a prospective and randomized study is needed to adequately assess these outcomes.</p>","PeriodicalId":14177,"journal":{"name":"International Journal of Nephrology","volume":"2020 ","pages":"2412396"},"PeriodicalIF":2.1,"publicationDate":"2020-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/2412396","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38649710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}